Vaccine "GC Flu Quadrivalent"

Active immunization of adults and children 6 months of age and older to prevent influenza caused by the influenza A virus subtypes and influenza B virus types contained in this vaccine.

Vaccination with the drug is contraindicated for the following categories of patients:

• patients with hypersensitivity to vaccine components;
• patients with hypersensitivity to eggs and chicken protein, another chicken component;
• patients with fever or insufficient nutrition;
• patients with chronic kidney or liver failure, acute cardiovascular and respiratory diseases, other infectious diseases;
• persons who had convulsions within 1 year before vaccination;
• patients with Guillain-Barré syndrome within 6 weeks after previous influenza vaccination or patients with neurological disorders;
• persons with immunodeficiency;
• patients until full recovery or persons in the incubation period of the disease;
• persons who have had a fever the day before or allergy symptoms, for example, a generalized rash with a previous vaccination.

Possible local reactions, such as:

• redness;
• edema;
• pain;

Common reactions such as:

• fever;
• chills;
• headache;
• increased fatigue;
• vomiting

Such reactions, as a rule, pass within 2-3 days.

Rarely, acute disseminated encephalomyelitis may develop.

Fever, headache, convulsions, dyskinesia, and confusion usually occur within 2 weeks of vaccine administration. If these symptoms are suspected, appropriate treatment is carried out, the diagnosis must be confirmed by MRI or other diagnostic methods.

Very rarely can be observed:

• allergic reaction;
• anaphylactic shock.

Temporary disorders of the central and peripheral nervous system are rarely possible. Cases were reported:

• paralysis;
• neuralgia;
• cerebral hemorrhage;
• inflammation of the nervous system (for example, Guillain-Barré syndrome).